324 related articles for article (PubMed ID: 23674603)
41. ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study.
Kubota-Ishida N; Kaji C; Matsumoto S; Wakabayashi T; Matsuhira T; Okura I; Cho N; Isshiki S; Kumura K; Tabata Y
Eur J Pharmacol; 2024 Jan; 962():176202. PubMed ID: 37996010
[TBL] [Abstract][Full Text] [Related]
42. Anti-allergic effects of Vernonia amygdalina leaf extracts in hapten-induced atopic dermatitis-like disease in mice.
Ngatu NR; Okajima MK; Yokogawa M; Hirota R; Takaishi M; Eitoku M; Muzembo BA; Sabah AB; Saruta T; Miyamura M; Kaneko T; Sano S; Suganuma N
Allergol Int; 2012 Dec; 61(4):597-607. PubMed ID: 22918214
[TBL] [Abstract][Full Text] [Related]
43. Topical application of an ethanol extract prepared from Illicium verum suppresses atopic dermatitis in NC/Nga mice.
Sung YY; Yang WK; Lee AY; Kim DS; Nho KJ; Kim YS; Kim HK
J Ethnopharmacol; 2012 Oct; 144(1):151-9. PubMed ID: 22971899
[TBL] [Abstract][Full Text] [Related]
44. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
45. DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.
Hunt DWC; Ivanova IA; Dagnino L
Tissue Barriers; 2020 Jul; 8(3):1765633. PubMed ID: 32479135
[TBL] [Abstract][Full Text] [Related]
46. Effect of taxifolin glycoside on atopic dermatitis-like skin lesions in NC/Nga mice.
Ahn JY; Choi SE; Jeong MS; Park KH; Moon NJ; Joo SS; Lee CS; Choi YW; Li K; Lee MK; Lee MW; Seo SJ
Phytother Res; 2010 Jul; 24(7):1071-7. PubMed ID: 20041431
[TBL] [Abstract][Full Text] [Related]
47. Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.
Zane LT; Chanda S; Jarnagin K; Nelson DB; Spelman L; Gold LS
Immunotherapy; 2016 Jul; 8(8):853-66. PubMed ID: 27283509
[TBL] [Abstract][Full Text] [Related]
48. A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.
Lehto M; Savinko T; Wolff H; Kvist PH; Kemp K; Lauerma A; Alenius H
Int Immunopharmacol; 2010 Apr; 10(4):377-84. PubMed ID: 20074670
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.
Chu Z; Xu Q; Zhu Q; Ma X; Mo J; Lin G; Zhao Y; Gu Y; Bian L; Shao L; Guo J; Ye W; Li J; He G; Xu Y
Eur J Med Chem; 2021 Mar; 213():113171. PubMed ID: 33482600
[TBL] [Abstract][Full Text] [Related]
50. Hypochlorous acid is antipruritic and anti-inflammatory in a mouse model of atopic dermatitis.
Fukuyama T; Martel BC; Linder KE; Ehling S; Ganchingco JR; Bäumer W
Clin Exp Allergy; 2018 Jan; 48(1):78-88. PubMed ID: 29028288
[TBL] [Abstract][Full Text] [Related]
51. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
52. Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis.
Fukuyama T; Ehling S; Cook E; Bäumer W
J Pharmacol Exp Ther; 2015 Sep; 354(3):394-405. PubMed ID: 26159873
[TBL] [Abstract][Full Text] [Related]
53. Atopic dermatitis: emerging therapies.
Simpson E; Udkoff J; Borok J; Tom W; Beck L; Eichenfield LF
Semin Cutan Med Surg; 2017 Sep; 36(3):124-130. PubMed ID: 28895959
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Cheong KA; Park CD; Lee AY
Scand J Immunol; 2012 May; 75(5):471-8. PubMed ID: 22023698
[TBL] [Abstract][Full Text] [Related]
55. Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
Kagawa Y; Izawa K; Yano H; Kamei C
Pharmacology; 2010; 85(5):286-94. PubMed ID: 20453552
[TBL] [Abstract][Full Text] [Related]
56. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
Noh SU; Cho EA; Kim HO; Park YM
Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
[TBL] [Abstract][Full Text] [Related]
57. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
Simon D; Vassina E; Yousefi S; Braathen LR; Simon HU
Allergy; 2005 Jul; 60(7):944-51. PubMed ID: 15932386
[TBL] [Abstract][Full Text] [Related]
58. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
59. Chronically relapsing pruritic dermatitis in the rats treated as neonate with capsaicin; a potential rat model of human atopic dermatitis.
Back SK; Jeong KY; Li C; Lee J; Lee SB; Na HS
J Dermatol Sci; 2012 Aug; 67(2):111-9. PubMed ID: 22721998
[TBL] [Abstract][Full Text] [Related]
60. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY
Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
